These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 28415652)
1. The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis. Peng Q; Zhang X; Min M; Zou L; Shen P; Zhu Y Oncotarget; 2017 Jul; 8(27):44893-44909. PubMed ID: 28415652 [TBL] [Abstract][Full Text] [Related]
2. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data. Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic value of microRNA-21 in colorectal cancer: an original study and individual participant data meta-analysis. Zhang H; Li P; Ju H; Pesta M; Kulda V; Jin W; Cai M; Liu C; Wu H; Xu J; Ye Y; Zhang G; Xu E; Cai J; Lai M; Xia D; Yang J; Wu Y Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2783-92. PubMed ID: 25178983 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis. Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132 [TBL] [Abstract][Full Text] [Related]
5. Prognostic role of microRNA-21 in colorectal cancer: a meta-analysis. Xia X; Yang B; Zhai X; Liu X; Shen K; Wu Z; Cai J PLoS One; 2013; 8(11):e80426. PubMed ID: 24265822 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of neutrophil gelatinase-associated lipocalin (NGAL) in colorectal cancer: a meta-analysis. Wang Y; Zeng TT Genet Mol Res; 2014 Feb; 13(3):7102-12. PubMed ID: 24634297 [TBL] [Abstract][Full Text] [Related]
7. Detection of microRNA-21 expression as a potential screening biomarker for colorectal cancer: a meta-analysis. Jiang JX; Zhang N; Liu ZM; Wang YY Asian Pac J Cancer Prev; 2014; 15(18):7583-8. PubMed ID: 25292032 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of miRNA-181a/b in colorectal cancer: a meta-analysis. Gu X; Jin R; Mao X; Wang J; Yuan J; Zhao G Biomark Med; 2018 Mar; 12(3):299-308. PubMed ID: 28841043 [TBL] [Abstract][Full Text] [Related]
9. Circulating miR-31 as an effective biomarker for detection and prognosis of human cancer: a meta-analysis. Ma Y; Chen Y; Lin J; Liu Y; Luo K; Cao Y; Wang T; Jin H; Su Z; Wu H; Chen X; Cheng J Oncotarget; 2017 Apr; 8(17):28660-28671. PubMed ID: 28404921 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic value of miR-106a in colorectal cancer. Hao H; Liu L; Zhang D; Wang C; Xia G; Zhong F; Hu X Oncotarget; 2017 Jan; 8(3):5038-5047. PubMed ID: 27926519 [TBL] [Abstract][Full Text] [Related]
11. Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis. Han S; Zong S; Shi Q; Li H; Liu S; Yang W; Li W; Hou F EBioMedicine; 2017 Jun; 20():61-69. PubMed ID: 28558958 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-92a as a potential biomarker in diagnosis of colorectal cancer: a systematic review and meta-analysis. Yang X; Zeng Z; Hou Y; Yuan T; Gao C; Jia W; Yi X; Liu M PLoS One; 2014; 9(2):e88745. PubMed ID: 24551148 [TBL] [Abstract][Full Text] [Related]
13. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis. Xu F; Xu L; Wang M; An G; Feng G Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351 [TBL] [Abstract][Full Text] [Related]
14. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients. Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of MicroRNAs in Stage II Colorectal Cancer Patients: A Systematic Review and Meta-Analysis. Sabarimurugan S; Madhav MR; Kumarasamy C; Gupta A; Baxi S; Krishnan S; Jayaraj R Mol Diagn Ther; 2020 Feb; 24(1):15-30. PubMed ID: 32020560 [TBL] [Abstract][Full Text] [Related]
16. The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis. Shao C; Yang F; Qin Z; Jing X; Shu Y; Shen H BMC Cancer; 2019 Nov; 19(1):1103. PubMed ID: 31727002 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of microRNA-628 for cancers. Li JH; Sun SS; Fu CJ; Zhang AQ; Wang C; Xu R; Xie SY; Wang PY J Cancer; 2018; 9(9):1623-1634. PubMed ID: 29760801 [No Abstract] [Full Text] [Related]
18. Biomarker roles identification of miR-106 family for predicting the risk and poor survival of colorectal cancer. Peng Q; Shen Y; Zhao P; Cheng M; Zhu Y; Xu B BMC Cancer; 2020 Jun; 20(1):506. PubMed ID: 32493303 [TBL] [Abstract][Full Text] [Related]